CHONGQING,China,Dec. 12,2024-- Recently,Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co.,Ltd. ("Aojin Life Sciences")
SK bioscience\'s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025,with interim results expected by 2026.
- A Milestone in Preventive Healthcare and Technological Innovation in Long An TÂN AN CITY,Vietnam,Dec. 12,2024-- Core8 Group,an Australian leader in high-tech and biotech innovation,has unveile
SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir
Anchored by next-generation IBM Quantum System Two in Illinois Quantum and Microelectronics Park,new initiative will advance useful quantum applications as industries move towards quantum-centric supe
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme
BEIJING,Dec. 12,2024-- Zhangzhou Pien Tze Huang Pharmaceutical Co.,Ltd.,a Fujian-based traditional Chinese medicine (TCM) company,has been striving to expand its overseas markets,enhancing the influen
BEIJING,Dec. 12,2024--The city of Shanghai is a first choice for many foreign tourists to learn about China. Join us in a video tour to Minhang District in Shanghai and explore the charm of intangible
XIAMEN,China,Dec. 13,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it
Keep the magic of Christmas alive with BLUETTI —powering every moment,wherever the season takes you.